...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel
【24h】

A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel

机译:一种具有热敏特性的新型混合胶束凝胶,用于多西他赛的局部递送

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, we incorporated docetaxel (DTX) into an injectable thermo-sensitive mixed micelle gel (MMG). It was found that the mixed micelle composed Of Pluronic F127 (PF127) and Tween 80 overcame the problem of PF127 micelle on physical stability and drug release due to the low solubilization capacity of PF127 for the high lipophility of DTX molecules. Then, DTX MMG was characterized in vitro and in vivo, compared with DTX PF127 gel and free DTX. The sulforhodamine B (SRB) staining assay in both human breast cancer MCF-7 and ovarian cancer SKOV-3 cell lines revealed that DTX loaded mixed micelles generated the highest cytotoxicity. Different local administrations, including intratumoral (i.t.), peritumoral (p.t.) and subcutaneous (s.c.) injections were compared and optimized in SKOV-3 ovarian tumor-xenograft bearing mice. Among these, the i.t. delivery of DTX MMG proved to be most effective. Moreover, it was demonstrated in the pharmacokinetic evaluation of DTX MMG that DTX remained in the tumor mass for more than six days post i.t. injection; likewise, we found that it correlated well with the in vitro release. During the observation period, there were no deaths, visible toxicity, nor obvious necrosis at the injection sites observed in all the animals tested. These results suggested that this injectable MMG system, provided a promising locally delivered vehicle for hydrophobic anti-tumor agents to increase their efficacy and thereby improved their therapeutic effect for clinical treatment.
机译:在本研究中,我们将多西他赛(DTX)掺入了可注射的热敏混合胶束凝胶(MMG)中。发现由Pluronic F127(PF127)和Tween 80组成的混合胶束克服了PF127胶束在物理稳定性和药物释放方面的问题,这是由于PF127对DTX分子的高亲脂性的溶解能力低。然后,与DTX PF127凝胶和游离DTX相比,在体外和体内对DTX MMG进行了表征。在人乳腺癌MCF-7和卵巢癌SKOV-3细胞系中的磺基罗丹明B(SRB)染色测定均显示DTX加载的混合胶束产生了最高的细胞毒性。在荷SKOV-3卵巢肿瘤异种移植小鼠中比较并优化了不同的局部给药方式,包括瘤内(i.t.),瘤周围(p.t.)和皮下(s.c.)注射。其中,i.t。 DTX MMG的交付被证明是最有效的。此外,在DTX MMG的药代动力学评估中证明,DTX在i.t.后6天仍保留在肿瘤块中。注射;同样,我们发现它与体外释放有很好的相关性。在观察期间,在所有测试的动物中观察到的注射部位没有死亡,可见的毒性或明显的坏死。这些结果表明,该可注射的MMG系统为疏水性抗肿瘤剂提供了有希望的局部递送载体,以提高其功效并由此改善其临床治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号